ImmuCell Corporation Announces Preliminary Unaudited Product Sales Results for the Year Ended December 31, 2019
January 21, 2020 at 05:30 pm
ImmuCell Corporation announced preliminary unaudited product sales results for the year ended December 31, 2019. Total product sales increased by approximately $2,700,000, or 25%, to approximately $13,700,000 during the year ended December 31, 2019 versus the year ended December 31, 2018. Total product sales increased by approximately $695,000, or 24%, to approximately $3,600,000 during the fourth quarter ended December 31, 2019 versus the comparable period during 2018.